Articles | Volume 6, issue 4
https://doi.org/10.5194/jbji-6-91-2021
https://doi.org/10.5194/jbji-6-91-2021
Original full-length article
 | 
27 Jan 2021
Original full-length article |  | 27 Jan 2021

One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty – a retrospective cohort study

F. Ruben H. A. Nurmohamed, Bruce van Dijk, Ewout S. Veltman, Marrit Hoekstra, Rob J. Rentenaar, Harrie H. Weinans, H. Charles Vogely, and Bart C. H. van der Wal

Viewed

Total article views: 1,554 (including HTML, PDF, and XML)
HTML PDF XML Total Supplement BibTeX EndNote
1,139 361 54 1,554 79 37 42
  • HTML: 1,139
  • PDF: 361
  • XML: 54
  • Total: 1,554
  • Supplement: 79
  • BibTeX: 37
  • EndNote: 42
Views and downloads (calculated since 27 Jan 2021)
Cumulative views and downloads (calculated since 27 Jan 2021)

Viewed (geographical distribution)

Total article views: 1,450 (including HTML, PDF, and XML) Thereof 1,448 with geography defined and 2 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 

Cited

Latest update: 13 Dec 2024
Download
Short summary
Literature reporting on the effectiveness of DAIR (debridement, antibiotics and implant retention) procedures performed after a one- or two-stage revision because of a prosthetic joint infection (PJI-related revision arthroplasty) is scarce. Infection control rates of a DAIR procedure after primary arthroplasty (n = 51) and after prior PJI-related revision arthroplasty (n = 16) were 69 % and 56 %, respectively. No statistically significant difference is found in infection control after 1 year.